Serological biomarkers for diagnosis of diabetes foot:A review of literature
10.3969/j.issn.1006-5725.2024.16.005
- VernacularTitle:糖尿病足血清学诊断标志物的研究进展
- Author:
Kaming YANG
1
;
Zhenlin LI
;
Wanwen LAO
;
Aixia ZHAI
;
Changlong BI
Author Information
1. 中山大学附属第八医院内分泌科(广东深圳 518033)
- Keywords:
diabetic foot;
diagnostic marker;
serological biomarkers
- From:
The Journal of Practical Medicine
2024;40(16):2224-2228
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic foot(DF),a primary chronic complication of diabetes mellitus,contributes to a major disability and mortality in diabetic patients.DF is diagnosed mainly depending not only on clinical manifestations,signs,and related inspection,but also on recently emerging diagnostic means:biological markers.Inflammatory biomarkers are preferably used for its superiority in DF early diagnosis.In recently years,thanks to advancements of biological technologies,biomarkers such as procalcitonin(PCT),C-reactive protein(CRP),interleukins(ILs),and tumor necrosis factor-alpha(TNF-α)have been comprehensively used in DF diagnosis.Moreover,biomarkers of genomics,proteomics,metabolomics,and metagenomics have been employed as well.In this review,we aim to com-prehensively review the role of serum biomarkers in DF diagnosis and risk stratification,elaborating on the current research status in applying serum biomarkers for DF prevention,diagnosis,and prognosis assessment.